Patents by Inventor Brian Renzelmann

Brian Renzelmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds and methods for the treatment of cancer
    Patent number: 8865764
    Abstract: The present invention provides organic arsenicals. Many of these compounds have potent in vitro cytotoxic activity against numerous human tumor cell lines, both of solid and hematological origin, as well as against malignant blood cells from patients with leukemia.
    Type: Grant
    Filed: November 14, 2012
    Date of Patent: October 21, 2014
    Assignee: Solasia Pharma K.K.
    Inventors: Paul Gutsch, Brian Renzelmann
  • Compounds and methods for the treatment of cancer
    Patent number: 8334398
    Abstract: The present invention provides organic arsenicals. Many of these compounds have potent in vitro cytotoxic activity against numerous human tumor cell lines, both of solid and hematological origin, as well as against malignant blood cells from patients with leukemia.
    Type: Grant
    Filed: June 1, 2011
    Date of Patent: December 18, 2012
    Assignee: Ziopharm Oncology, Inc.
    Inventors: Paul Gutsch, Brian Renzelmann
  • COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20120022229
    Abstract: The present invention provides organic arsenicals. Many of these compounds have potent in vitro cytotoxic activity against numerous human tumor cell lines, both of solid and hematological origin, as well as against malignant blood cells from patients with leukemia.
    Type: Application
    Filed: June 1, 2011
    Publication date: January 26, 2012
    Applicant: Ziopharm Oncology, Inc.
    Inventors: Paul Gutsch, Brian Renzelmann
  • Compounds and methods for the treatment of cancer
    Patent number: 7968738
    Abstract: The present invention provides organic arsenicals. Many of these compounds have potent in vitro cytotoxic activity against numerous human tumor cell lines, both of solid and hematological origin, as well as against malignant blood cells from patients with leukemia.
    Type: Grant
    Filed: July 28, 2006
    Date of Patent: June 28, 2011
    Assignee: ZIOPHARM Oncology, Inc.
    Inventors: Paul Gutsch, Brian Renzelmann
  • Compounds and methods for the treatment of cancer
    Publication number: 20070183972
    Abstract: The present invention provides organic arsenicals. Many of these compounds have potent in vitro cytotoxic activity against numerous human tumor cell lines, both of solid and hematological origin, as well as against malignant blood cells from patients with leukemia.
    Type: Application
    Filed: July 28, 2006
    Publication date: August 9, 2007
    Applicant: ZIOPHARM Oncology, Inc.
    Inventors: Paul Gutsch, Brian Renzelmann